Skip to main content

Advertisement

SpringerLink
Log in

Metrics of Aging in Transplantation

  • Frailty and Gerontology (M McAdams-Demarco, Section Editor)​
  • Published:
Current Transplantation Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To describe potential metrics of aging beyond chronological age and their associations with outcomes after solid organ transplantation.

Recent Findings

Investigation in this field has focused primarily on two areas: biomarkers related to replicative cell senescence and frailty and constructs related to frailty (e.g., sarcopenia, physical performance). Indicators of replicative senescence and frailty are more prevalent among transplant candidates than in the general elderly population, and both have been shown in recent studies to be associated with adverse outcomes following transplantation.

Summary

Despite substantial evidence supporting the prognostic utility of these indicators, and of physical frailty in particular, no consensus has emerged about the best metric within individual organ specialty groups or across specialties. Research is ongoing to identify the most useful measure or set of measures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Grams ME, Kucirka LM, Hanrahan CF, Montgomery RA, Massie AB, Segev DL. Candidacy for kidney transplantation of older adults. J Am Geriatr Soc. 2012;60(1):1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2001;1(Suppl 2):3–95.

    Google Scholar 

  3. Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation. 2007;83(8):1069–74.

    Article  PubMed  Google Scholar 

  4. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30.

    Article  CAS  PubMed  Google Scholar 

  5. Huang E, Segev DL, Rabb H. Kidney transplantation in the elderly. Semin Nephrol. 2009;29(6):621–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3s1):A7.

    Article  PubMed  PubMed Central  Google Scholar 

  7. World Health Organization. World report on ageing and health. Geneva, Switzerland; 2015.

  8. Kloda K, Domanski L, Mierzecki A. Telomere length assessment for prediction of organ transplantation outcome. Future or failure: a review of the literature. Med Sci Monit. 2017;23:158–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004;101(49):17312–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell. 2008;7(4):491–7.

    Article  CAS  PubMed  Google Scholar 

  11. McGlynn LM, Stevenson K, Lamb K, Zino S, Brown M, Prina A, et al. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell. 2009;8(1):45–51.

    Article  CAS  PubMed  Google Scholar 

  12. Gingell-Littlejohn M, McGuinness D, McGlynn LM, Kingsmore D, Stevenson KS, Koppelstaetter C, et al. Pre-transplant CDKN2A expression in kidney biopsies predicts renal function and is a future component of donor scoring criteria. PLoS One. 2013;8(7):e68133.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ferlicot S, Durrbach A, Ba N, Desvaux D, Bedossa P, Paradis V. The role of replicative senescence in chronic allograft nephropathy. Hum Pathol. 2003;34(9):924–8.

    Article  PubMed  Google Scholar 

  14. Kloda K, Mierzecki A, Domanski L, Borowiecka E, Safranow K, Ciechanowicz A, et al. Joint assessment of donor and recipient hTERT gene polymorphism provides additional information for early kidney transplantation outcomes. Med Sci Monit. 2017;23:1812–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Oetting WS, Guan W, Schladt DP, Wildebush WA, Becker J, Thyagarajan B, et al. Telomere length of recipients and living kidney donors and chronic graft dysfunction in kidney transplants. Transplantation. 2014;97(3):325–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Dlouha D, Vancura V, Vymetalova J, Hubacek JA, Lanska V, Malek I. Can leukocyte telomere length predict survival time in heart transplant recipients over a minimal follow-up of 20 years? Folia Biol. 2016;62(5):188–93.

    CAS  Google Scholar 

  17. Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, et al. Association of donor and recipient telomere length with clinical outcomes following lung transplantation. PLoS One. 2016;11(9):e0162409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. McAdams-DeMarco MA, James N, Salter ML, Walston J, Segev DL. Trends in kidney transplant outcomes in older adults. J Am Geriatr Soc. 2014;62(12):2235–42.

    PubMed  PubMed Central  Google Scholar 

  19. Kutner NG, Zhang R, Bowles T, Painter P. Pretransplant physical functioning and kidney patients’ risk for posttransplantation hospitalization/death: evidence from a national cohort. Clin J Am Soc Nephrol. 2006;1(4):837–43.

    Article  PubMed  Google Scholar 

  20. Reese PP, Shults J, Bloom RD, Mussell A, Harhay MN, Abt P, et al. Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. Am J Kidney Dis. 2015;66(5):837–45.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Reese PP, Bloom RD, Shults J, Thomasson A, Mussell A, Rosas SE, et al. Functional status and survival after kidney transplantation. Transplantation. 2014;97(2):189–95.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392–7.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue QL, et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53–61.

    Article  PubMed  Google Scholar 

  24. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci. 2001;56A(3):M146–M56.

    Article  Google Scholar 

  26. Schuurmans H, Steverink N, Lindenberg S, Frieswijk N, Slaets JP. Old or frail: what tells us more? J Gerontol A Biol Sci Med Sci. 2004;59(9):M962–5.

    Article  PubMed  Google Scholar 

  27. Gobbens RJ, Schols JM, van Assen MA. Exploring the efficiency of the Tilburg Frailty Indicator: a review. Clin Interv Aging. 2017;12:1739–52.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gobbens RJ, van Assen MA, Luijkx KG, Wijnen-Sponselee MT, Schols JM. The Tilburg Frailty Indicator: psychometric properties. J Am Med Dir Assoc. 2010;11(5):344–55.

    Article  PubMed  Google Scholar 

  29. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. TheScientificWorldJOURNAL. 2001;1:323–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Mitnitski AB, Song X, Rockwood K. The estimation of relative fitness and frailty in community-dwelling older adults using self-report data. J Gerontol A Biol Sci Med Sci. 2004;59(6):M627–32.

    Article  PubMed  Google Scholar 

  31. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35(5):526–9.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Abellan van Kan G, Rolland YM, Morley JE, Vellas B. Frailty: toward a clinical definition. J Am Med Dir Assoc. 2008;9(2):71–2.

    Article  PubMed  Google Scholar 

  33. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol Ser B Psychol Sci Soc Sci. 1998;53(1):S9–16.

    Article  CAS  Google Scholar 

  34. Bouillon K, Kivimaki M, Hamer M, Sabia S, Fransson EI, Singh-Manoux A, et al. Measures of frailty in population-based studies: an overview. BMC Geriatr. 2013;13:64.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm--issues and controversies. J Gerontol A Biol Sci Med Sci. 2007;62(7):731–7.

    Article  PubMed  Google Scholar 

  36. Rodriguez-Manas L, Feart C, Mann G, Vina J, Chatterji S, Chodzko-Zajko W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68(1):62–7.

    Article  PubMed  Google Scholar 

  37. Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18(11):2960–7.

    Article  PubMed  Google Scholar 

  38. Bao Y, Dalrymple L, Chertow G, Kaysen G, Johansen K. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med. 2012;172(14):1071–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. McAdams-Demarco M, Law A, Salter M, Boyarsky B, Gimenez L, Jaar B, et al. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc. 2013;61(6):896–901.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Meulendijks FG, Hamaker ME, Boereboom FT, Kalf A, Vogtlander NP, van Munster BC. Groningen frailty indicator in older patients with end-stage renal disease. Ren Fail. 2015;37(9):1419–24.

    Article  CAS  PubMed  Google Scholar 

  41. Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK. Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol. 2015;10(5):832–40.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Iyasere OU, Brown EA, Johansson L, Huson L, Smee J, Maxwell AP, et al. Quality of life and physical function in older patients on dialysis: a comparison of assisted peritoneal dialysis with hemodialysis. Clin J Am Soc Nephrol. 2016;11(3):423–30.

    Article  CAS  PubMed  Google Scholar 

  43. Johansen KL, Dalrymple LS, Glidden D, Delgado C, Kaysen GA, Grimes B, et al. Association of performance-based and self-reported function-based definitions of frailty with mortality among patients receiving hemodialysis. Clin J Am Soc Nephrol. 2016;11(4):626–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Chao CT, Chiang CK, Huang JW, Hung KY. Self-reported frailty among end-stage renal disease patients: a potential predictor of dialysis access outcomes. Nephrology (Carlton). 2017;22(4):333–4.

    Article  Google Scholar 

  45. Lee SY, Yang DH, Hwang E, Kang SH, Park SH, Kim TW, et al. The prevalence, association, and clinical outcomes of frailty in maintenance dialysis patients. J Ren Nutr. 2017;27(2):106–12.

    Article  PubMed  Google Scholar 

  46. Delgado C, Shieh S, Grimes B, Chertow GM, Dalrymple LS, Kaysen GA, et al. Association of self-reported frailty with falls and fractures among patients new to dialysis. Am J Nephrol. 2015;42(2):134–40.

    Article  PubMed  Google Scholar 

  47. McAdams-DeMarco MA, Suresh S, Law A, Salter ML, Gimenez LF, Jaar BG, et al. Frailty and falls among adult patients undergoing chronic hemodialysis: a prospective cohort study. BMC Nephrol. 2013;14:224.

    Article  PubMed  PubMed Central  Google Scholar 

  48. McAdams-DeMarco MA, Law A, Salter ML, Chow E, Grams M, Walston J, et al. Frailty and early hospital readmission after kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(8):2091–5.

    Article  CAS  Google Scholar 

  49. Yadla M, John JP, Mummadi M. A study of clinical assessment of frailty in patients on maintenance hemodialysis supported by cashless government scheme. Saudi J Kidney Dis Transpl. 2017;28(1):15–22.

    Article  PubMed  Google Scholar 

  50. Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(8):1870–9.

    Article  CAS  Google Scholar 

  51. Cron DC, Friedman JF, Winder GS, Thelen AE, Derck JE, Fakhoury JW, et al. Depression and frailty in patients with end-stage liver disease referred for transplant evaluation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2016;16(6):1805–11.

    Article  CAS  Google Scholar 

  52. Guaraldi G, Dolci G, Zona S, Tarantino G, Serra V, Ballarin R, et al. A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients. AIDS Res Ther. 2017;14(1):37.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Sinclair M, Poltavskiy E, Dodge JL, Lai JC. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist. World J Gastroenterol. 2017;23(5):899–905.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Tapper EB, Konerman M, Murphy S, Sonnenday CJ. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2018;18:2566–70.

    Article  Google Scholar 

  55. Dunlay SM, Park SJ, Joyce LD, Daly RC, Stulak JM, McNallan SM, et al. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant. 2014;33(4):359–65.

    Article  PubMed  Google Scholar 

  56. Jha SR, Hannu MK, Chang S, Montgomery E, Harkess M, Wilhelm K, et al. The prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation. Transplantation. 2016;100(2):429–36.

    Article  PubMed  Google Scholar 

  57. Joseph SM, Manghelli JL, Vader JM, Keeney T, Novak EL, Felius J, et al. Prospective assessment of frailty using the Fried criteria in patients undergoing left ventricular assist device therapy. Am J Cardiol. 2017;120(8):1349–54.

    Article  PubMed  Google Scholar 

  58. Moayedi Y, Duero Posada JG, Foroutan F, Goldraich LA, Alba AC, MacIver J, et al. The prognostic significance of frailty compared to peak oxygen consumption and B-type natriuretic peptide in patients with advanced heart failure. Clin transplant. 2018;32(1).

  59. Singer JP, Diamond JM, Gries CJ, McDonnough J, Blanc PD, Shah R, et al. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med. 2015;192(11):1325–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Wilson ME, Vakil AP, Kandel P, Undavalli C, Dunlay SM, Kennedy CC. Pretransplant frailty is associated with decreased survival after lung transplantation. J Heart Lung Transplant. 2016;35(2):173–8.

    Article  PubMed  Google Scholar 

  61. •• Garonzik-Wang JM, Govindan P, Grinnan JW, Liu M, Ali HM, Chakraborty A, et al. Frailty and delayed graft function in kidney transplant recipients. Arch Surg. 2012;147(2):190–3 This study prospectively assessed frailty by the Fried Frailty Index among patients and kidney transplant recipients and found that pre-transplant frailty was associated with delayed graft function.

    Article  PubMed  Google Scholar 

  62. McAdams-DeMarco MA, King EA, Luo X, Haugen C, DiBrito S, Shaffer A, et al. Frailty, length of stay, and mortality in kidney transplant recipients: a national registry and prospective cohort study. Ann Surg. 2017;266(6):1084–90.

    Article  PubMed  Google Scholar 

  63. McAdams-DeMarco MA, Law A, King E, Orandi B, Salter M, Gupta N, et al. Frailty and mortality in kidney transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(1):149–54.

    Article  CAS  Google Scholar 

  64. McAdams-DeMarco MA, Isaacs K, Darko L, Salter ML, Gupta N, King EA, et al. Changes in frailty after kidney transplantation. J Am Geriatr Soc. 2015;63(10):2152–7.

    Article  PubMed  PubMed Central  Google Scholar 

  65. McAdams-DeMarco MA, Olorundare IO, Ying H, Warsame F, Haugen CE, Hall R, et al. Frailty and postkidney transplant health-related quality of life. Transplantation. 2018;102(2):291–9.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Centers for Medicare and Medicaid Services. Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Fed Regist. 2007;72(61):15197–280.

    Google Scholar 

  67. Dolgin NH, Martins PN, Movahedi B, Lapane KL, Anderson FA, Bozorgzadeh A. Functional status predicts postoperative mortality after liver transplantation. Clin Transpl. 2016;30(11):1403–10.

    Article  Google Scholar 

  68. Derck JE, Thelen AE, Cron DC, Friedman JF, Gerebics AD, Englesbe MJ, et al. Quality of life in liver transplant candidates: frailty is a better indicator than severity of liver disease. Transplantation. 2015;99(2):340–4.

    Article  PubMed  Google Scholar 

  69. •• Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66(2):564–74 This study applied the Fried frailty phenotype among candidates for liver transplantation and found that frailty was assoicated with higher mortality.

    Article  PubMed  Google Scholar 

  70. Lai JC, Segev DL, McCulloch CE, Covinsky KE, Dodge JL, Feng S. Physical frailty after liver transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2018.

  71. Joseph SM, Rich MW. Targeting frailty in heart failure. Curr Treat Options Cardiovasc Med. 2017;19(4):31.

    Article  PubMed  Google Scholar 

  72. Joyce E. Frailty in advanced heart failure. Heart Fail Clin. 2016;12(3):363–74.

    Article  PubMed  Google Scholar 

  73. Cacciatore F, Abete P, Mazzella F, Viati L, Della Morte D, D’Ambrosio D, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Investig. 2005;35(12):723–30.

    Article  CAS  Google Scholar 

  74. Madan SA, Fida N, Barman P, Sims D, Shin J, Verghese J, et al. Frailty assessment in advanced heart failure. J Card Fail. 2016;22(10):840–4.

    Article  PubMed  Google Scholar 

  75. Lupon J, Gonzalez B, Santaeugenia S, Altimir S, Urrutia A, Mas D, et al. Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Esp Cardiol. 2008;61(8):835–42.

    Article  PubMed  Google Scholar 

  76. Jha SR, Hannu MK, Gore K, Chang S, Newton P, Wilhelm K, et al. Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation. J Heart Lung Transplant. 2016;35(9):1092–100.

    Article  PubMed  Google Scholar 

  77. Jha SR, Hannu MK, Newton PJ, Wilhelm K, Hayward CS, Jabbour A, et al. Reversibility of frailty after bridge-to-transplant ventricular assist device implantation or heart transplantation. Transplant direct. 2017;3(7):e167.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, et al. Inclusion of sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol. 2015;6:e102.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transplant. 2012;18(10):1209–16.

    Article  Google Scholar 

  81. Izumi T, Watanabe J, Tohyama T, Takada Y. Impact of psoas muscle index on short-term outcome after living donor liver transplantation. Turk J Gastroenterol. 2016;27(4):382–8.

    Article  PubMed  Google Scholar 

  82. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211(2):271–8.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Heberton GA, Nassif M, Bierhals A, Novak E, LaRue SJ, Lima B, et al. Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation. Am J Cardiol. 2016;118(9):1363–7.

    Article  PubMed  Google Scholar 

  84. Bibas L, Saleh E, Al-Kharji S, Chetrit J, Mullie L, Cantarovich M, et al. Muscle mass and mortality after cardiac transplantation. Transplantation. 2018.

  85. Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016;63(2):574–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hennepin Healthcare, 701 Park Avenue, Minneapolis, MN, 55415, USA

    Kirsten L. Johansen

Authors
  1. Kirsten L. Johansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kirsten L. Johansen.

Ethics declarations

Conflict of Interest

Kirsten Johansen receives personal fees from Glaxo-SmithKline, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Frailty and Gerontology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johansen, K.L. Metrics of Aging in Transplantation. Curr Transpl Rep 6, 36–44 (2019). https://doi.org/10.1007/s40472-019-0229-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40472-019-0229-x

Keywords

Search

Navigation